- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intranasal Insulin for Alzheimer’s Disease ; volume:35 ; number:1 ; day:30 ; month:1 ; year:2021 ; pages:21-37 ; date:1.2021
CNS drugs ; 35, Heft 1 (30.1.2021), 21-37, 1.2021
- Urheber
-
Hallschmid, Manfred
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-020-00781-x
- URN
-
urn:nbn:de:101:1-2021042121031076814359
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
16.08.2025, 10:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hallschmid, Manfred
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diabetes, insulin and Alzheimer's disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Alzheimer’s Disease
Photoaffinity Probes for Alzheimer’s Disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer's disease
Active immunotherapy options for Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Diabetes, insulin and Alzheimer's disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Alzheimer’s Disease
Photoaffinity Probes for Alzheimer’s Disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer's disease
Active immunotherapy options for Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies
Diabetes, insulin and Alzheimer's disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Impairment of insulin signaling pathway in Alzheimer’s disease
Alzheimer’s Disease
Photoaffinity Probes for Alzheimer’s Disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Alzheimer's disease
Active immunotherapy options for Alzheimer’s disease
Urinary metabolic phenotyping for Alzheimer’s disease
Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease